Authors: Berry-Kravis E, Krause SE, Block SS, Guter S, Wuu J, Leurgans S, Decle P, Potanos K, Cook E, Salt J, Maino D, Weinberg D, Lara R, Jardini T, Cogswell J, Johnson SA, Hagerman R
Title: Effect of CX516, an AMPA-Modulating Compound, on Cognition and Behavior in Fragile X Syndrome: A Controlled Trial
Source: Journal of Child and Adolescent Psychopharmacology 2006 16(5): 525-540
Year: 2006
Research Design: Randomised Controlled Trial
Rating Score: 09/10
This rating is confirmed
Eligibility specified - Y
Random allocation - Y
Concealed allocation - Y
Baseline comparability - Y
Blind subjects - Y
Blind therapists - N
Blind assessors - Y
Adequate follow-up - Y
Intention-to-treat analysis - Y
Between-group comparisons - Y
Point estimates and variability - Y
Abstract:

Copyright release for this abstract has not been obtained.
Access: Paywall